Reuben Ben‐David
Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
Papers
18
Total Citations
76
H-Index
5
About
Reuben Ben-David is a leading urologic oncologist whose research focuses on the surgical management of upper tract urothelial carcinoma (UTUC) and bladder cancer, with a particular emphasis on robotic-assisted techniques. As a key contributor to the ROBUUST 2.0 collaborative group, he has been instrumental in generating real-world evidence from over 1,100 patients undergoing robot-assisted nephroureterectomy, demonstrating the safety and mid-term oncological efficacy of this approach. His work has critically examined the role of neoadjuvant chemotherapy in locally advanced UTUC, the prognostic impact of diagnostic ureteroscopy, and the comparative effectiveness of single-dose intravesical gemcitabine versus mitomycin C after nephroureterectomy. Beyond UTUC, Ben-David has advanced the field of robotic radical cystectomy for both non-muscle-invasive and muscle-invasive bladder cancer, including analyses of intracorporeal neobladder outcomes and the impact of immunotherapy-based neoadjuvant regimens on postoperative complications. With over 60 citations across his most influential papers, his collaborative, multi-institutional studies have shaped contemporary guidelines and surgical decision-making. He has also contributed to surgical education, surveying the impact of single-port robotic platforms on urology trainees.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10